✦ LIBER ✦

Prognostic factors in patients with aggressive non-Hodgkin’s lymphoma without complete response to first-line therapy

✍ Scribed by Suleyman Alici; Sevil Bavbek; Mert Basaran; Haluk Onat

Book ID: 105633549
Publisher: Springer Healthcare Communications
Year: 2006
Tongue: English
Weight: 278 KB
Volume: 23
Category: Article
ISSN: 0741-238X
DOI: 10.1007/bf02850042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dexamethasone, etoposide, ifosfamide, an

Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-hodgkin's lymphoma

✍ Nissim Haim; Menachem Ben-Shahar; David Faraggi; Avital Tsuri-Etzioni; Michelle 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. This study analyzed the long term results of a combination of dexa-

A prospective study of intensive inducti

A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin’s lymphoma and two or three adverse prognostic factors

✍ Dumontet, C; Thieblemont, C; Espinouse, D; Bouafia, F; Hequet, O; Salles, G; Coi 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Response to second-line chemotherapy in

Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment : Prognostic factors

✍ Bernard Brun; Mohamed Benchalal; Christelle Lebas; Pascal Piedbois; Ma Lin; Jean 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

tic factors associated with response to a second-line chemotherapy in patients with metastatic breast carcinoma (MBC) that was previously responsive to a first-

A phase III trial comparing CHOP to PMit

A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma

✍ Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, M J S; Hancock, B; Mouncey, P 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

Prognostic features and outcome in patie

Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens

✍ Luis Villela; Armando López-Guillermo; Silvia Montoto; Susana Rives; Francesc Bo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Standard chemotherapy is superior to hig

Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis

✍ Jing Wang; Ping Zhan; Jian Ouyang; Bing Chen; Rongfu Zhou; Yonggong Yang 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 219 KB